115 related articles for article (PubMed ID: 28092860)
21. Design and synthesis of a novel class EGFR/HER2 dual inhibitors containing tricyclic oxazine fused quinazolines scaffold.
Sun M; Jia J; Sun H; Wang F
Bioorg Med Chem Lett; 2020 May; 30(9):127045. PubMed ID: 32139324
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity study of quinazoline derivatives leading to the discovery of potent EGFR-T790M inhibitors.
Zhang L; Yang Y; Zhou H; Zheng Q; Li Y; Zheng S; Zhao S; Chen D; Fan C
Eur J Med Chem; 2015 Sep; 102():445-63. PubMed ID: 26310890
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Biological Evaluation of Artemisinin-Piperazine-Phosphoramide Mustard Hybrids as Potential Anticancer Agents.
Wei MX; Zhang SS; Sun X; Ji Y; Yang PW; Li XQ
ChemMedChem; 2022 Sep; 17(17):e202200239. PubMed ID: 35771689
[TBL] [Abstract][Full Text] [Related]
24. Dual EGFR/HER2 inhibitors and apoptosis inducers: New benzo[g]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers.
Ghorab MM; Alsaid MS; Soliman AM
Bioorg Chem; 2018 Oct; 80():611-620. PubMed ID: 30041137
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
He J; Wang X; Zhao X; Liang Y; He H; Fu L
Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
[TBL] [Abstract][Full Text] [Related]
27. Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities.
Xi JB; Fang YF; Frett B; Zhu ML; Zhu T; Kong YN; Guan FJ; Zhao Y; Zhang XW; Li HY; Ma ML; Hu W
Eur J Med Chem; 2017 Jan; 126():1083-1106. PubMed ID: 28039836
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of novel androgen-linked phosphoramide mustard prodrugs and growth-inhibitory activity in human breast cancer cells.
Roth T; Tang W; Eisenbrand G
Anticancer Drug Des; 1995 Dec; 10(8):655-66. PubMed ID: 8595124
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of novel 7-aminosubstituted pyrido[2,3-b]pyrazines exhibiting anti-breast cancer activity.
Argyros O; Lougiakis N; Kouvari E; Papafotika A; Raptopoulou CP; Psycharis V; Christoforidis S; Pouli N; Marakos P; Tamvakopoulos C
Eur J Med Chem; 2017 Jan; 126():954-968. PubMed ID: 28006668
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antineoplastic activity of a novel series of phosphoramide mustard analogues of pyrimidine deoxyribonucleosides.
Lin TS; Fischer PH; Prusoff WH
J Med Chem; 1980 Nov; 23(11):1235-7. PubMed ID: 7452673
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of novel pyrazolo[1,5-a]pyrimidine derivatives bearing nitrogen mustard moiety and evaluation of their antitumor activity in vitro and in vivo.
Zhao M; Ren H; Chang J; Zhang D; Yang Y; He Y; Qi C; Zhang H
Eur J Med Chem; 2016 Aug; 119():183-96. PubMed ID: 27162123
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of phosphoramide mustard analogues of daunomycin and carminomycin.
Csorvási A; Kövér KE; Menyhárt MM; Sztaricskai F; Dobrynin YV; Nikolaeva TG
Arch Pharm (Weinheim); 1998 Sep; 331(9):265-8. PubMed ID: 9793480
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of novel 4-phenoxy-6,7-disubstituted quinolines possessing (thio)semicarbazones as c-Met kinase inhibitors.
Zhai X; Bao G; Wang L; Cheng M; Zhao M; Zhao S; Zhou H; Gong P
Bioorg Med Chem; 2016 Mar; 24(6):1331-45. PubMed ID: 26897090
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
Struck RF; Schmid SM; Waud WR
Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.
Bae I; Kim D; Choi J; Kim J; Kim M; Park B; Kim YH; Ahn YG; Hyung Kim H; Kim DK
Bioorg Med Chem Lett; 2021 Feb; 34():127676. PubMed ID: 33166687
[TBL] [Abstract][Full Text] [Related]
37. Phenylalanyl-aminocyclophosphamides as model prodrugs for proteolytic activation: synthesis, stability, and stereochemical requirements for enzymatic cleavage.
Jiang Y; Hu L
Bioorg Med Chem Lett; 2007 Jan; 17(2):517-21. PubMed ID: 17064897
[TBL] [Abstract][Full Text] [Related]
38. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
Lu L; Zhao TT; Liu TB; Sun WX; Xu C; Li DD; Zhu HL
Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1570-1575. PubMed ID: 27568484
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and investigation of novel 6-(1,2,3-triazol-4-yl)-4-aminoquinazolin derivatives possessing hydroxamic acid moiety for cancer therapy.
Ding C; Chen S; Zhang C; Hu G; Zhang W; Li L; Chen YZ; Tan C; Jiang Y
Bioorg Med Chem; 2017 Jan; 25(1):27-37. PubMed ID: 27769671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
